Through the Expanding Maternal and Neonatal Survival (EMAS) Project, Jhpiego improved the quality of maternal and newborn care by expanding clinical governance and evidence-based service delivery in six provinces of Indonesia. The Ministry of Health adopted the hospital mentorship model developed by Jhpiego Indonesia, and 80 districts have replicated components of EMAS in at least 12 provinces of Indonesia.
Jhpiego works with the Ministry of Health to raise awareness about cervical cancer in communities and improve access for women to HPV DNA screening services and treatment and referral as needed.
Cervical cancer is the second leading cause of cancer related deaths among women in Indonesia, with nearly twice the mortality rate compared to the global average. Jhpiego Indonesia, in partnership with Roche Pharmaceuticals, is implementing the Cervical Cancer Screening Project (CCSP), a pilot program using self-sampling for HPV DNA testing that is grounded in evidence-based approaches. Jhpiego provides technical assistance to strengthen health systems in areas such as developing behavior change communication, improving clinical competencies, expanding access to laboratory services, and supporting the development of sustainable service delivery models.
We develop a replicable approach that includes community outreach, clinical workflows, and laboratory integration, serving as a model for government-led scale-up of cervical cancer screening nationwide.
The program educates and mobilizes communities about cervical cancer prevention and screening. It works end-to-end with stakeholders, from community advocacy to thermal ablation treatment. In less than two of the eight-month implementation period, 45% of the target population was reached through self-sampling.
Additional support includes setting up laboratory workflows, engaging women for screening, and ensuring timely follow-up of test results. This initiative aligns with Indonesia’s National Cervical Cancer Elimination Plan (2023–2030) and helps equip the Ministry of Health with essential information to scale up HPV DNA screening nationwide.